NCT07260162
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07260162
Title Evaluation of Safety, Tolerability and Response of ATO-10 in Patients With Non-Muscle-Invasive Bladder Cancer (PERSEVERANCE EU) (PERSEVERANCE)
Acronym PERSEVERANCE
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Institut Cancerologie de l'Ouest
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Institut de Cancérologie de l'Ouest Saint-Herblain Loire Atlantique 44800 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field